--- title: "The \"Implementation Rules for the Supervision and Administration of the Use of Medical Security Fund\" have been announced and will take effect on April 1" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/275907951.md" description: "The \"Implementation Rules for the Supervision and Administration of Medical Security Fund Usage\" were passed on February 12, 2026, and will take effect on April 1, 2026. The rules require medical security handling agencies to suspend the settlement and payment of expenses for designated medical institutions suspected of defrauding the medical security fund at the request of the medical security administrative department, until they cooperate with the investigation. During the suspension period, if the medical expenses are confirmed to be fraudulent after investigation, they will be handled according to relevant regulations; if not, they will be settled according to regulations after the suspension is lifted" datetime: "2026-02-13T13:32:18.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275907951.md) - [en](https://longbridge.com/en/news/275907951.md) - [zh-HK](https://longbridge.com/zh-HK/news/275907951.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/275907951.md) | [English](https://longbridge.com/en/news/275907951.md) # The "Implementation Rules for the Supervision and Administration of the Use of Medical Security Fund" have been announced and will take effect on April 1 The "Implementation Rules for the Supervision and Administration of the Use of Medical Security Fund" have been reviewed and approved by the State Medical Security Administration's executive meeting on February 12, 2026, and are now published, coming into effect on April 1, 2026. It is stated that medical security handling agencies shall, at the request of the medical security administrative department, suspend the settlement of medical security funds and the disbursement of expenses for designated medical institutions suspected of defrauding medical security fund expenditures and refusing to cooperate with investigations, until the designated medical institutions cooperate with the investigation ### 相關股票 - [Aier (300015.CN)](https://longbridge.com/zh-HK/quote/300015.CN.md) - [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-HK/quote/512010.CN.md) - [Ping An CSI Medicine and Medical Device Innovation ETF (516820.CN)](https://longbridge.com/zh-HK/quote/516820.CN.md) - [GX CN MEDTECH (02841.HK)](https://longbridge.com/zh-HK/quote/02841.HK.md) ## 相關資訊與研究 - [Jiangsu Hengrui Pharmaceuticals Gets China Nod for Two Anti-Tumor Injectables](https://longbridge.com/zh-HK/news/278349440.md) - [SSY Gets China Nod for Production, Registration of Vitamin Injection](https://longbridge.com/zh-HK/news/279036594.md) - [Qyuns Therapeutics' Arthritis Drug Crusekitug Accepted for Review in China; Shares Jump 11%](https://longbridge.com/zh-HK/news/278491064.md) - [China Medical System Gets China Nod to Market Renal Anaemia Drug](https://longbridge.com/zh-HK/news/279046722.md) - [Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/zh-HK/news/279032574.md)